(MedPage Today) — In January 2025, we reported that some adverse events associated with gabapentin (Neurontin) may have been overestimated. Since then, new risks related to gabapentin emerged and prescribing continued to rise. Here’s what we learned…
Source:
Read full article at www.medpagetoday.com
Medical Disclaimer:
This content is for informational and educational purposes only.
It does not replace professional medical advice.






